BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 18596061)

  • 1. Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase.
    Tamamori-Adachi M; Takagi H; Hashimoto K; Goto K; Hidaka T; Koshimizu U; Yamada K; Goto I; Maejima Y; Isobe M; Nakayama KI; Inomata N; Kitajima S
    Cardiovasc Res; 2008 Nov; 80(2):181-90. PubMed ID: 18596061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulating myocyte cell cycle control for cardiac repair.
    Gorr TA; Deten A
    Cardiovasc Res; 2008 Nov; 80(2):161-2. PubMed ID: 18779229
    [No Abstract]   [Full Text] [Related]  

  • 3. Myocardial regeneration therapy for ischemic cardiomyopathy with cyclin A2.
    Woo YJ; Panlilio CM; Cheng RK; Liao GP; Suarez EE; Atluri P; Chaudhry HW
    J Thorac Cardiovasc Surg; 2007 Apr; 133(4):927-33. PubMed ID: 17382628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction.
    Ding L; Dong L; Chen X; Zhang L; Xu X; Ferro A; Xu B
    Circulation; 2009 Sep; 120(9):764-73. PubMed ID: 19687354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function.
    Jayasankar V; Bish LT; Pirolli TJ; Berry MF; Burdick J; Woo YJ
    Ann Thorac Surg; 2004 Jun; 77(6):2122-9; discussion 2129. PubMed ID: 15172279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
    Jayasankar V; Pirolli TJ; Bish LT; Berry MF; Burdick J; Grand T; Woo YJ
    J Mol Cell Cardiol; 2004 Apr; 36(4):531-8. PubMed ID: 15081312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation.
    Wu YJ; Bond M; Sala-Newby GB; Newby AC
    Circ Res; 2006 May; 98(9):1141-50. PubMed ID: 16574903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure.
    Berry MF; Pirolli TJ; Jayasankar V; Morine KJ; Moise MA; Fisher O; Gardner TJ; Patterson PH; Woo YJ
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):866-75. PubMed ID: 15573071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation.
    Tamamori-Adachi M; Ito H; Sumrejkanchanakij P; Adachi S; Hiroe M; Shimizu M; Kawauchi J; Sunamori M; Marumo F; Kitajima S; Ikeda MA
    Circ Res; 2003 Jan; 92(1):e12-9. PubMed ID: 12522130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
    Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
    Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocyte survivin protein expression is associated with cell size and DNA content in the failing human heart and is reversibly regulated after ventricular unloading.
    Wohlschlaeger J; Meier B; Schmitz KJ; Takeda A; Takeda N; Vahlhaus C; Levkau B; Stypmann J; Schmid C; Schmid KW; Baba HA
    J Heart Lung Transplant; 2010 Nov; 29(11):1286-92. PubMed ID: 20851637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWEAK is a positive regulator of cardiomyocyte proliferation.
    Novoyatleva T; Diehl F; van Amerongen MJ; Patra C; Ferrazzi F; Bellazzi R; Engel FB
    Cardiovasc Res; 2010 Mar; 85(4):681-90. PubMed ID: 19887380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho GTPase, Rac1, regulates Skp2 levels, vascular smooth muscle cell proliferation, and intima formation in vitro and in vivo.
    Bond M; Wu YJ; Sala-Newby GB; Newby AC
    Cardiovasc Res; 2008 Nov; 80(2):290-8. PubMed ID: 18599477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic effect of p21Cip1 on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation.
    Bond M; Sala-Newby GB; Wu YJ; Newby AC
    Cardiovasc Res; 2006 Jan; 69(1):198-206. PubMed ID: 16212951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells.
    Supriatno ; Harada K; Yoshida H; Sato M
    Int J Oncol; 2005 Sep; 27(3):627-35. PubMed ID: 16077910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats.
    Gäbel R; Klopsch C; Furlani D; Yerebakan C; Li W; Ugurlucan M; Ma N; Steinhoff G
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):20-5; discussion 25. PubMed ID: 19380336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between myocyte proliferation and cardiac function in adult rats with heart failure].
    Li H; He JG; Liu QH; Deng DJ; Wu ZJ; Guo WY; Ding JF; Cheng XS
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):102-5. PubMed ID: 16620714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of chronic heart failure by overexpressing sarcoplasmic reticulum calcium ATPase through gene therapy: an experiment with rats].
    Li XY; Hui HP; Lu XC; Guo YT
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1174-8. PubMed ID: 16796857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells.
    Winter EM; van Oorschot AA; Hogers B; van der Graaf LM; Doevendans PA; Poelmann RE; Atsma DE; Gittenberger-de Groot AC; Goumans MJ
    Circ Heart Fail; 2009 Nov; 2(6):643-53. PubMed ID: 19919990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.